PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MIRM vs. TGTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MIRM and TGTX is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

MIRM vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mirum Pharmaceuticals, Inc. (MIRM) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

200.00%250.00%300.00%350.00%400.00%NovemberDecember2025FebruaryMarchApril
195.99%
380.80%
MIRM
TGTX

Key characteristics

Sharpe Ratio

MIRM:

1.20

TGTX:

2.76

Sortino Ratio

MIRM:

2.08

TGTX:

3.46

Omega Ratio

MIRM:

1.26

TGTX:

1.41

Calmar Ratio

MIRM:

1.93

TGTX:

1.74

Martin Ratio

MIRM:

6.52

TGTX:

19.39

Ulcer Index

MIRM:

9.64%

TGTX:

8.96%

Daily Std Dev

MIRM:

52.38%

TGTX:

63.05%

Max Drawdown

MIRM:

-63.78%

TGTX:

-100.00%

Current Drawdown

MIRM:

-26.45%

TGTX:

-99.97%

Fundamentals

Market Cap

MIRM:

$1.93B

TGTX:

$6.02B

EPS

MIRM:

-$1.85

TGTX:

$0.15

PS Ratio

MIRM:

5.74

TGTX:

18.29

PB Ratio

MIRM:

8.57

TGTX:

27.07

Total Revenue (TTM)

MIRM:

$267.67M

TGTX:

$265.53M

Gross Profit (TTM)

MIRM:

$203.85M

TGTX:

$232.41M

EBITDA (TTM)

MIRM:

-$33.56M

TGTX:

$58.28M

Returns By Period

In the year-to-date period, MIRM achieves a -5.44% return, which is significantly lower than TGTX's 27.31% return.


MIRM

YTD

-5.44%

1M

-17.04%

6M

-0.91%

1Y

65.89%

5Y*

21.60%

10Y*

N/A

TGTX

YTD

27.31%

1M

-9.77%

6M

64.39%

1Y

173.91%

5Y*

26.81%

10Y*

8.77%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MIRM vs. TGTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MIRM
The Risk-Adjusted Performance Rank of MIRM is 8989
Overall Rank
The Sharpe Ratio Rank of MIRM is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of MIRM is 8888
Sortino Ratio Rank
The Omega Ratio Rank of MIRM is 8484
Omega Ratio Rank
The Calmar Ratio Rank of MIRM is 9393
Calmar Ratio Rank
The Martin Ratio Rank of MIRM is 9191
Martin Ratio Rank

TGTX
The Risk-Adjusted Performance Rank of TGTX is 9696
Overall Rank
The Sharpe Ratio Rank of TGTX is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of TGTX is 9797
Sortino Ratio Rank
The Omega Ratio Rank of TGTX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of TGTX is 9393
Calmar Ratio Rank
The Martin Ratio Rank of TGTX is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MIRM vs. TGTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mirum Pharmaceuticals, Inc. (MIRM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MIRM, currently valued at 1.20, compared to the broader market-2.00-1.000.001.002.003.00
MIRM: 1.20
TGTX: 2.76
The chart of Sortino ratio for MIRM, currently valued at 2.08, compared to the broader market-6.00-4.00-2.000.002.004.00
MIRM: 2.08
TGTX: 3.46
The chart of Omega ratio for MIRM, currently valued at 1.26, compared to the broader market0.501.001.502.00
MIRM: 1.26
TGTX: 1.41
The chart of Calmar ratio for MIRM, currently valued at 1.93, compared to the broader market0.001.002.003.004.00
MIRM: 1.93
TGTX: 2.29
The chart of Martin ratio for MIRM, currently valued at 6.52, compared to the broader market-5.000.005.0010.0015.0020.00
MIRM: 6.52
TGTX: 19.39

The current MIRM Sharpe Ratio is 1.20, which is lower than the TGTX Sharpe Ratio of 2.76. The chart below compares the historical Sharpe Ratios of MIRM and TGTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.20
2.76
MIRM
TGTX

Dividends

MIRM vs. TGTX - Dividend Comparison

Neither MIRM nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MIRM vs. TGTX - Drawdown Comparison

The maximum MIRM drawdown since its inception was -63.78%, smaller than the maximum TGTX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for MIRM and TGTX. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-26.45%
-30.20%
MIRM
TGTX

Volatility

MIRM vs. TGTX - Volatility Comparison

The current volatility for Mirum Pharmaceuticals, Inc. (MIRM) is 11.43%, while TG Therapeutics, Inc. (TGTX) has a volatility of 13.07%. This indicates that MIRM experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
11.43%
13.07%
MIRM
TGTX

Financials

MIRM vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Mirum Pharmaceuticals, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab